Roche Holding shares rose 2.1% Wednesday after the Swiss drugmaker reported positive results from a new study of an experimental breast cancer drug. The pill, giredestrant, reduced the risk of death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback